Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1999 Jul;36(7):554–560.

Angelman syndrome resulting from UBE3A mutations in 14 patients from eight families: clinical manifestations and genetic counselling

A Moncla 1, P Malzac 1, M Livet 1, M Voelckel 1, J Mancini 1, J C Delaroziere 1, N Philip 1, J Mattei 1
PMCID: PMC1734398  PMID: 10424818

Abstract

Angelman syndrome (AS) is a neurological disorder with a heterogeneous genetic aetiology. It most frequently results from a de novo interstitial deletion in the 15q11-q13 region, but in a few cases it is caused by paternal uniparental disomy (UPD) or an imprinting mutation. The remaining 20 to 30% of AS patients exhibit biparental inheritance and a normal pattern of allelic methylation in the 15q11-q13 region. In this latter group, mutations in the UBE3A gene have recently been shown to be a cause of AS. Here we describe the phenotypic expression in 14 AS cases involving eight UBE3A mutations. These comprise 11 familial cases from five families and three sporadic cases. Subtle differences from the typical phenotype of AS were found. Consistent manifestations were psychomotor delay, a happy disposition, a hyperexcitable personality, EEG abnormalities, and mental retardation with severe speech impairment. The other main manifestations of AS, ataxia, epilepsy, and microcephaly, were either milder or absent in various combinations among the patients. In addition, myoclonus of cortical origin was frequently observed with severe fits inducing myoclonic seizures. The majority of the patients were overweight. This study showed that ataxia, myoclonus, EEG abnormalities, speech impairment, characteristic behavioural phenotype, and abnormal head circumference are attributable to a deficiency in the maternally inherited UBE3A allele. Furthermore, analysis of mutation transmission showed an unexpectedly high rate of somatic mosaicism in normal carriers. These data have important consequences for genetic counselling.


Keywords: Angelman syndrome; cortical myoclonus; UBE3A mutation; somatic mosaicism

Full Text

The Full Text of this article is available as a PDF (134.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baraitser M., Patton M., Lam S. T., Brett E. M., Wilson J. The Angelman (Happy Puppet) syndrome: is it autosomal recessive? Clin Genet. 1987 May;31(5):323–330. doi: 10.1111/j.1399-0004.1987.tb02816.x. [DOI] [PubMed] [Google Scholar]
  2. Boyd S. G., Harden A., Patton M. A. The EEG in early diagnosis of the Angelman (happy puppet) syndrome. Eur J Pediatr. 1988 Jun;147(5):508–513. doi: 10.1007/BF00441976. [DOI] [PubMed] [Google Scholar]
  3. Buntinx I. M., Hennekam R. C., Brouwer O. F., Stroink H., Beuten J., Mangelschots K., Fryns J. P. Clinical profile of Angelman syndrome at different ages. Am J Med Genet. 1995 Mar 27;56(2):176–183. doi: 10.1002/ajmg.1320560213. [DOI] [PubMed] [Google Scholar]
  4. Chan C. T., Clayton-Smith J., Cheng X. J., Buxton J., Webb T., Pembrey M. E., Malcolm S. Molecular mechanisms in Angelman syndrome: a survey of 93 patients. J Med Genet. 1993 Nov;30(11):895–902. doi: 10.1136/jmg.30.11.895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clayton-Smith J. Clinical research on Angelman syndrome in the United Kingdom: observations on 82 affected individuals. Am J Med Genet. 1993 Apr 1;46(1):12–15. doi: 10.1002/ajmg.1320460105. [DOI] [PubMed] [Google Scholar]
  6. Clayton-Smith J., Webb T., Robb S. A., Dijkstra I., Willems P., Lam S., Cheng X. J., Pembrey M. E., Malcolm S. Further evidence for dominant inheritance at the chromosome 15q11-13 locus in familial Angelman syndrome. Am J Med Genet. 1992 Sep 15;44(2):256–260. doi: 10.1002/ajmg.1320440236. [DOI] [PubMed] [Google Scholar]
  7. Fang P., Lev-Lehman E., Tsai T. F., Matsuura T., Benton C. S., Sutcliffe J. S., Christian S. L., Kubota T., Halley D. J., Meijers-Heijboer H. The spectrum of mutations in UBE3A causing Angelman syndrome. Hum Mol Genet. 1999 Jan;8(1):129–135. doi: 10.1093/hmg/8.1.129. [DOI] [PubMed] [Google Scholar]
  8. Fung D. C., Yu B., Cheong K. F., Smith A., Trent R. J. UBE3A "mutations" in two unrelated and phenotypically different Angelman syndrome patients. Hum Genet. 1998 Apr;102(4):487–492. doi: 10.1007/s004390050727. [DOI] [PubMed] [Google Scholar]
  9. Guerrini R., De Lorey T. M., Bonanni P., Moncla A., Dravet C., Suisse G., Livet M. O., Bureau M., Malzac P., Genton P. Cortical myoclonus in Angelman syndrome. Ann Neurol. 1996 Jul;40(1):39–48. doi: 10.1002/ana.410400109. [DOI] [PubMed] [Google Scholar]
  10. Huibregtse J. M., Scheffner M., Beaudenon S., Howley P. M. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2563–2567. doi: 10.1073/pnas.92.7.2563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jiang Y. H., Armstrong D., Albrecht U., Atkins C. M., Noebels J. L., Eichele G., Sweatt J. D., Beaudet A. L. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron. 1998 Oct;21(4):799–811. doi: 10.1016/s0896-6273(00)80596-6. [DOI] [PubMed] [Google Scholar]
  12. Jiang Y., Tsai T. F., Bressler J., Beaudet A. L. Imprinting in Angelman and Prader-Willi syndromes. Curr Opin Genet Dev. 1998 Jun;8(3):334–342. doi: 10.1016/s0959-437x(98)80091-9. [DOI] [PubMed] [Google Scholar]
  13. Kishino T., Lalande M., Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet. 1997 Jan;15(1):70–73. doi: 10.1038/ng0197-70. [DOI] [PubMed] [Google Scholar]
  14. Kyllerman M. On the prevalence of Angelman syndrome. Am J Med Genet. 1995 Nov 20;59(3):405–404. doi: 10.1002/ajmg.1320590331. [DOI] [PubMed] [Google Scholar]
  15. Malzac P., Webber H., Moncla A., Graham J. M., Kukolich M., Williams C., Pagon R. A., Ramsdell L. A., Kishino T., Wagstaff J. Mutation analysis of UBE3A in Angelman syndrome patients. Am J Hum Genet. 1998 Jun;62(6):1353–1360. doi: 10.1086/301877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Matsuura T., Sutcliffe J. S., Fang P., Galjaard R. J., Jiang Y. H., Benton C. S., Rommens J. M., Beaudet A. L. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet. 1997 Jan;15(1):74–77. doi: 10.1038/ng0197-74. [DOI] [PubMed] [Google Scholar]
  17. Meijers-Heijboer E. J., Sandkuijl L. A., Brunner H. G., Smeets H. J., Hoogeboom A. J., Deelen W. H., van Hemel J. O., Nelen M. R., Smeets D. F., Niermeijer M. F. Linkage analysis with chromosome 15q11-13 markers shows genomic imprinting in familial Angelman syndrome. J Med Genet. 1992 Dec;29(12):853–857. doi: 10.1136/jmg.29.12.853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pashayan H. M., Singer W., Bove C., Eisenberg E., Seto B. The Angelman syndrome in two brothers. Am J Med Genet. 1982 Nov;13(3):295–298. doi: 10.1002/ajmg.1320130311. [DOI] [PubMed] [Google Scholar]
  19. Robb S. A., Pohl K. R., Baraitser M., Wilson J., Brett E. M. The 'happy puppet' syndrome of Angelman: review of the clinical features. Arch Dis Child. 1989 Jan;64(1):83–86. doi: 10.1136/adc.64.1.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rougeulle C., Glatt H., Lalande M. The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain. Nat Genet. 1997 Sep;17(1):14–15. doi: 10.1038/ng0997-14. [DOI] [PubMed] [Google Scholar]
  21. Saitoh S., Harada N., Jinno Y., Hashimoto K., Imaizumi K., Kuroki Y., Fukushima Y., Sugimoto T., Renedo M., Wagstaff J. Molecular and clinical study of 61 Angelman syndrome patients. Am J Med Genet. 1994 Aug 15;52(2):158–163. doi: 10.1002/ajmg.1320520207. [DOI] [PubMed] [Google Scholar]
  22. Stalker H. J., Williams C. A. Genetic counseling in Angelman syndrome: the challenges of multiple causes. Am J Med Genet. 1998 Apr 28;77(1):54–59. [PubMed] [Google Scholar]
  23. Wagstaff J., Knoll J. H., Glatt K. A., Shugart Y. Y., Sommer A., Lalande M. Maternal but not paternal transmission of 15q11-13-linked nondeletion Angelman syndrome leads to phenotypic expression. Nat Genet. 1992 Jul;1(4):291–294. doi: 10.1038/ng0792-291. [DOI] [PubMed] [Google Scholar]
  24. Wagstaff J., Shugart Y. Y., Lalande M. Linkage analysis in familial Angelman syndrome. Am J Hum Genet. 1993 Jul;53(1):105–112. [PMC free article] [PubMed] [Google Scholar]
  25. Williams C. A., Angelman H., Clayton-Smith J., Driscoll D. J., Hendrickson J. E., Knoll J. H., Magenis R. E., Schinzel A., Wagstaff J., Whidden E. M. Angelman syndrome: consensus for diagnostic criteria. Angelman Syndrome Foundation. Am J Med Genet. 1995 Mar 27;56(2):237–238. doi: 10.1002/ajmg.1320560224. [DOI] [PubMed] [Google Scholar]
  26. Zori R. T., Hendrickson J., Woolven S., Whidden E. M., Gray B., Williams C. A. Angelman syndrome: clinical profile. J Child Neurol. 1992 Jul;7(3):270–280. doi: 10.1177/088307389200700307. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES